Delivery Order SPE2DB20D3103-SPE2DB22FP3A7
Award Date
7/25/22
Potential Completion Date
7/26/22
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,811.00 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of June 25, 2024 and was awarded on June 24, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,667.40 and an ultimate completion date of April 21, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the...
This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and does not have a set-aside designation. The contract is a delivery order with a firm fixed price of $7,735.95 and a completion date of September 11, 2024. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other...
This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $11,433.00 firm fixed-price contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 4, 2024. The award has an ultimate completion date of June 5, 2024 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGE to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $18,540.74, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of July 10, 2024. Amerisourcebergen holds a...
This federal contract award is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,025.00, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 4, 2024. This award is not associated with a set-aside designation,...
This federal contract award is for the supply of HAVRIX 720 unit/0.5 mL syringes to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at $3,143.04, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 24, 2024. The contract is a delivery order with a firm fixed price and an ultimate completion date of April 25, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug...
This federal contract award is for the delivery of Havrix 1,440 units/mL syringes to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $2,664.93 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The $4,131.24 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2024. The contract is not set aside for any specific business type....
The Defense Logistics Agency (DLA) awarded a $3,055.68 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product. This order falls under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of...